Celsion Corporation to Present at Upcoming Investor Conferences
March 12 2018 - 7:00AM
-- Celsion Corporation (NASDAQ: CLSN), an oncology drug
development company, today announced that Michael Tardugno,
Chairman, President and Chief Executive Officer, will present at
the following upcoming investor conferences:
- The B. Riley FBR Inaugural China Healthcare Investing &
Partnering Symposium (CHIPS) on Friday, March 16, 2018 at 3:30 p.m.
local time. The conference will be held March 15-17, 2018 at The
InterContinental Hotel Hangzhou, China.
- The Oppenheimer 28th Annual Healthcare Conference on Tuesday,
March 20, 2018 at 9:10 a.m. EDT. The conference will be held March
20-21, 2018 at The Westin New York Grand Central in New York
City.
A live webcast of Celsion’s presentation at the
Oppenheimer conference may be accessed by visiting the “News &
Investors” section of Celsion’s corporate website at
www.celsion.com. A replay of the webcast will also be available and
archived on the site for 90 days following the presentation or
until June 19, 2018.
About Celsion
Corporation
Celsion is a fully-integrated oncology company
focused on developing a portfolio of innovative cancer treatments,
including directed chemotherapies, immunotherapies and RNA- or
DNA-based therapies. The Company's lead program is ThermoDox®, a
proprietary heat-activated liposomal encapsulation of doxorubicin,
currently in Phase III development for the treatment of primary
liver cancer and in Phase II development for the treatment of
recurrent chest wall breast cancer. The pipeline also
includes GEN-1, a DNA-based immunotherapy for the localized
treatment of ovarian and brain cancers. Celsion has two
platform technologies for the development of novel nucleic
acid-based immunotherapies and other anti-cancer DNA or RNA
therapies. For more information on Celsion, visit our
website: www.celsion.com. (CLSN-FIN)
ThermoDox® is a registered trademark of Celsion
Corporation.
Celsion Investor Contact
Jeffrey W. Church
Sr. Vice President and CFO
609-482-2455
jchurch@celsion.com
Celsion (NASDAQ:CLSN)
Historical Stock Chart
From Apr 2024 to May 2024
Celsion (NASDAQ:CLSN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Celsion Corporation (NASDAQ): 0 recent articles
More News Articles